713 related articles for article (PubMed ID: 27406374)
1. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.
Aswathyraj S; Arunkumar G; Alidjinou EK; Hober D
Med Microbiol Immunol; 2016 Oct; 205(5):397-407. PubMed ID: 27406374
[TBL] [Abstract][Full Text] [Related]
2. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
3. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
Mao Q; Wang Y; Bian L; Xu M; Liang Z
Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
[TBL] [Abstract][Full Text] [Related]
4. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
Fang CY; Liu CC
Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
[TBL] [Abstract][Full Text] [Related]
5. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
[TBL] [Abstract][Full Text] [Related]
6. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems.
Bian L; Gao F; Mao Q; Sun S; Wu X; Liu S; Yang X; Liang Z
Expert Rev Anti Infect Ther; 2019 Apr; 17(4):233-242. PubMed ID: 30793637
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology and clinical features of hand, foot and mouth disease in northern Thailand in 2016: a prospective cohort study.
Upala P; Apidechkul T; Suttana W; Kullawong N; Tamornpark R; Inta C
BMC Infect Dis; 2018 Dec; 18(1):630. PubMed ID: 30522440
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses].
Cui P; Li Y; Zhou CC; Zhou YH; Song CL; Qiu Q; Wang F; Guo C; Han SJ; Liang L; Yuan Y; Zeng MY; Yue J; Long L; Qin XH; Li Z; Chen XL; Zou YP; Cheng YB; Yu HJ
Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):445-451. PubMed ID: 31216802
[No Abstract] [Full Text] [Related]
9. Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014-2016, prior to the introduction of the enterovirus 71 vaccine.
Li J; Pan H; Wang X; Zhu Q; Ge Y; Cai J; Li Y; Xia A; Hu J; Zeng M
Emerg Microbes Infect; 2018 Mar; 7(1):37. PubMed ID: 29559626
[TBL] [Abstract][Full Text] [Related]
10. [Hand-Foot-and-Mouth Disease, Aseptic Meningitis, and Encephalitis Caused by Enterovirus].
Fujimoto T
Brain Nerve; 2018 Feb; 70(2):121-131. PubMed ID: 29433113
[TBL] [Abstract][Full Text] [Related]
11. Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: Essential information for rational vaccine design.
Hoa-Tran TN; Dao ATH; Nguyen AT; Kataoka C; Takemura T; Pham CH; Vu HM; Hong TTT; Ha NTV; Duong TN; Thanh NTH; Shimizu H
Vaccine; 2020 Dec; 38(52):8273-8285. PubMed ID: 33223308
[TBL] [Abstract][Full Text] [Related]
12. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013.
Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Xu M; Li XL; Zhu FC; Liang ZL
J Med Virol; 2015 Dec; 87(12):2009-17. PubMed ID: 26010334
[TBL] [Abstract][Full Text] [Related]
13. Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul.
Ceylan AN; Turel O; Gultepe BS; Inan E; Turkmen AV; Doymaz MZ
Pol J Microbiol; 2019; 68(2):165-171. PubMed ID: 31257789
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden.
Ji H; Fan H; Lu PX; Zhang XF; Ai J; Shi C; Huo X; Bao CJ; Shan J; Jin Y
BMC Infect Dis; 2019 Jan; 19(1):79. PubMed ID: 30669973
[TBL] [Abstract][Full Text] [Related]
15. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013-2014.
Yao X; Bian LL; Lu WW; Li JX; Mao QY; Wang YP; Gao F; Wu X; Ye Q; Li XL; Zhu FC; Liang Z
Hum Vaccin Immunother; 2017 Apr; 13(4):823-830. PubMed ID: 27768527
[TBL] [Abstract][Full Text] [Related]
17. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
[TBL] [Abstract][Full Text] [Related]
18. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain.
Cabrerizo M; Tarragó D; Muñoz-Almagro C; Del Amo E; Domínguez-Gil M; Eiros JM; López-Miragaya I; Pérez C; Reina J; Otero A; González I; Echevarría JE; Trallero G
Clin Microbiol Infect; 2014 Mar; 20(3):O150-6. PubMed ID: 24033818
[TBL] [Abstract][Full Text] [Related]
20. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
